Genetic epilepsies generally present in children aged 2–10 years, during the developmental phase when the neural network undergoes ‘pruning’, and often spontaneously remit. Idiopathic epilepsies are common in dogs and in some breeds are ten times more common than in humans. It was previously reported that the Lagotto romagnolo breed exhibits an epileptic disorder with onset at ∼7 weeks (equivalent to age 2 years in humans) and remit at ∼4 months (age 8 years in humans). Seppälä et al. now report the genetic defect and affected neurological pathways underlying this phenotype. Mapping studies showed that the genetic defect results in truncation of the secreted neuronal protein LGI2, preventing its secretion and interaction with three ADAM-family neuronal membrane receptors. LGI2 mutations have not been associated with human epilepsy, but autosomal dominant lateral temporal lobe epilepsy (ADLTE) is associated with mutations in LGI1, which interacts with the same ADAM-family receptors. These interactions are thought to stabilize synapses, and LGI1 seems to protect the brain against seizures during and/or after the pruning phase. By contrast, the authors propose, based on LGI gene expression data, that LGI2 might be important for preventing seizures early during development of the neural network, before pruning. These results suggest that LGI2 should be considered as a candidate gene in childhood epilepsies.
Understanding epilepsy in a canine model
Understanding epilepsy in a canine model. Dis Model Mech 1 September 2011; 4 (5): 558. doi:
Download citation file:
Advertisement
Cited by
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Other journals from
The Company of Biologists